Skip to main content

Marina Rigau Resina

Institutions of which they are part

Postdoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca
Marina Rigau Resina

Marina Rigau Resina

Marina Rigau Resina

Institutions of which they are part

Postdoctoral researcher
Biomedical Research in Gynaecology
Vall Hebron Institut de Recerca

Projects

Desarrollo de Marcadores y Terapias en Cáncer de Endometrio Avanzado

IP: Antonio Gil Moreno
Collaborators: Angel García Jiménez, Maria Asuncion Perez Benavente, Fco Javier De la Torre Fdez de Vega, Josep Castellví Vives, Silvia Cabrera Diaz, Marina Rigau Resina
Funding agency: Instituto de Salud Carlos III
Funding: 147620
Reference: PI14/02043
Duration: 01/01/2015 - 30/06/2019

European Network on Microvesicles and Exosomes in Health and Disease (ME-HAD)

IP: -
Collaborators: Jaume Reventós Puigjaner, Marina Rigau Resina, Jaume Reventós Puigjaner, Jaume Reventós Puigjaner, Jaume Reventós Puigjaner, Jaume Reventós Puigjaner
Funding agency: EUROPEAN COMMISSION
Funding: 1
Reference: ME-HAD_BM1202 _COST2012
Duration: 07/12/2012 - 30/04/2017

Unitat de Recerca Biomèdica i Oncologia Translacional (GRC)

IP: Jaume Reventós Puigjaner
Collaborators: José Placer Santos, Joan Morote Robles, Maria Asuncion Perez Benavente, Eva Colas Ortega, Berta Diaz Feijoo, Silvia Cabrera Diaz, Antonio Gil Moreno, Marina Rigau Resina, Jacques Planas Morin
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 50000
Reference: 2014 SGR 1330
Duration: 01/01/2014 - 31/12/2016

Red Temática de Investigación Cooperativa en Cáncer - RTICC

IP: Jaume Reventós Puigjaner
Collaborators: Joan Morote Robles, Inés de Torres Ramirez, Maria Asuncion Perez Benavente, Eva Colas Ortega, Silvia Cabrera Diaz, Antonio Gil Moreno, Rosanna Paciucci Barzanti, Marina Rigau Resina, Carles Xavier Raventós Busquets, Jacques Planas Morin, Anna Santamaria Margalef
Funding agency: Instituto de Salud Carlos III
Funding: 229500
Reference: RD12/0036/0035
Duration: 01/01/2013 - 30/06/2017

Related news

From 6th to 7th March, more than 60 European researchers have shared the advances in translational research in endometrial cancer

On January 24, a session was held to explain what these three-dimensional models are and what advantages they have, as well as to review some of their applications in research.

A team from Vall d'Hebron Research Institute (VHIR) and the Autonomous University of Barcelona (UAB) highlights the ERK5 protein as a key factor in the resistance to cancer drugs.

Related professionals

Borja González Rodríguez

Borja González Rodríguez

Reconstructive Surgery of the Locomotor System
Read more
Joana Rita Marques Soares

Joana Rita Marques Soares

Predoctoral researcher
Systemic Diseases
Read more
Maria Pilar Redondo Gonzalez

Maria Pilar Redondo Gonzalez

Research assistant
Microbiology
Read more
Silvia Muñoz Caller

Silvia Muñoz Caller

Research technician
Psychiatry, Mental Health and Addictions
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.